![Hironori Narita](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Hironori Narita
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
DCI Partners KK
![]() DCI Partners KK Investment ManagersFinance DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan.
4
| Subsidiary | Investment Managers | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hironori Narita
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
HOGY MEDICAL CO.,LTD. | Medical Specialties | Director/Board Member | |
AGP KK | Founder | ||
ASANTE INCORPORATED | Miscellaneous Commercial Services | Director/Board Member | |
KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member | |
Junten Bio Co. Ltd.
![]() Junten Bio Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
NOILE-IMMUNE BIOTECH INC. | Pharmaceuticals: Major | Director/Board Member | |
REGiMMUNE Corp.
![]() REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
University of Tsukuba | College/University | Graduate Degree | |
Tokyo University of Science | College/University | Graduate Degree | |
Daiwa Corporate Investment Co., Ltd.
![]() Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment Co. Ltd. (Daiwa Corporate Investment) is a private equity arm of Daiwa Securities Group Inc. and is headquartered in Tokyo, Japan. The firm was founded in 1982. | Investment Managers | Comptroller/Controller/Auditor |
Statistik
International
Japan | 11 |
Sektoral
Health Technology | 5 |
Commercial Services | 3 |
Consumer Services | 3 |
Finance | 2 |
Operativ
Director/Board Member | 10 |
Private Equity Investor | 3 |
Independent Dir/Board Member | 2 |
Graduate Degree | 2 |
Comptroller/Controller/Auditor | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Hironori Narita
- Unternehmensverbindungen